ukoniq.com valuation and analysis

Robots.txt Information
Robot Path Permission
GoogleBot /
BingBot /
BaiduSpider /
YandexBot /
Meta Tags
Title Our Products – TG
Description Fiercely Focused On BRIUMVI ® (ublituximab-xiiy) IS NOW APPROVED. PRESCRIBING INFORMATION ABOUT US Our Story Message From Our CEO Leadership Team Board Members Guiding Princi
Keywords N/A
Server Information
WebSite ukoniq faviconukoniq.com
Host IP 155.130.138.30
Location United States
Related Websites
Site Rank
More to Explore
ukoniq.com Valuation
US$1,911
Last updated: 2023-05-11 11:41:25

ukoniq.com has Semrush global rank of 0. ukoniq.com has an estimated worth of US$ 1,911, based on its estimated Ads revenue. ukoniq.com receives approximately 220 unique visitors each day. Its web server is located in United States, with IP address 155.130.138.30. According to SiteAdvisor, ukoniq.com is safe to visit.

Traffic & Worth Estimates
Purchase/Sale Value US$1,911
Daily Ads Revenue US$1
Monthly Ads Revenue US$52
Yearly Ads Revenue US$635
Daily Unique Visitors 14
Note: All traffic and earnings values are estimates.
DNS Records
Host Type TTL Data
ukoniq.com. A 599 IP: 155.130.138.30
ukoniq.com. NS 3600 NS Record: pdns07.domaincontrol.com.
ukoniq.com. NS 3600 NS Record: pdns08.domaincontrol.com.
HtmlToTextCheckTime:2023-05-11 11:41:25
BRIUMVI ® (ublituximab-xiiy) IS NOW APPROVED. PRESCRIBING INFORMATION ABOUT US Our Story Message From Our CEO Leadership Team Board Members Guiding Principles Join Us OUR SCIENCE Our Approach Our Focus MZL/FL CLL MS Collaborate With Us Meet with TG Medical OUR PRODUCTS OUR PIPELINE Overview Umbralisib Ublituximab TG-1501 TG-1701 TG 1801 OUR PUBLICATIONS OUR TRIALS Trial Information Expanded Access Policy INVESTORS & MEDIA Press Releases Stock Information Historic Stock Lookup Sec Filings & Financials Quarterly Results Annual Reports SEC Filings Events IR & Media Contact Leadership Team Corporate Governance Faqs Mobile Menu Mobile Close ABOUT US Our Story Message From Our CEO Leadership Team Board Members Guiding Principles Join Us OUR SCIENCE Our Approach Our Focus MZL/FL CLL MS Collaborate With Us Meet with TG Medical OUR PRODUCTS OUR PIPELINE Overview Umbralisib Ublituximab TG-1501 TG-1701 TG 1801 OUR PUBLICATIONS OUR TRIALS Trial Information Expanded Access Policy INVESTORS & MEDIA
HTTP Headers
HTTP/1.1 301 Moved Permanently
Server: nginx
Date: Thu, 04 Nov 2021 16:33:41 GMT
Content-Type: text/html
Content-Length: 162
Connection: keep-alive
Location: https://ukoniq.com/

HTTP/2 200 
server: nginx
date: Thu, 04 Nov 2021 16:33:41 GMT
content-type: text/html
content-length: 56292
x-accel-version: 0.01
last-modified: Fri, 02 Jul 2021 16:02:08 GMT
etag: "dbe4-5c62613e20602"
accept-ranges: bytes
strict-transport-security: max-age=63072000; includeSubDomains
x-powered-by: PleskLin
ukoniq.com Whois Information
Domain Name: UKONIQ.COM
Registry Domain ID: 2452533768_DOMAIN_COM-VRSN
Registrar WHOIS Server: whois.godaddy.com
Registrar URL: http://www.godaddy.com
Updated Date: 2020-12-19T15:13:15Z
Creation Date: 2019-11-07T19:23:26Z
Registry Expiry Date: 2022-11-07T19:23:26Z
Registrar: GoDaddy.com, LLC
Registrar IANA ID: 146
Registrar Abuse Contact Email: abuse@godaddy.com
Registrar Abuse Contact Phone: 480-624-2505
Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited
Domain Status: clientRenewProhibited https://icann.org/epp#clientRenewProhibited
Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited
Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited
Name Server: PDNS07.DOMAINCONTROL.COM
Name Server: PDNS08.DOMAINCONTROL.COM
DNSSEC: unsigned
>>> Last update of whois database: 2021-12-22T08:34:58Z <<<